PT100517A - Compostos inibidores de catepsina g e de elastase para a prevencao da degenerescencia do tecido conjuntivo - Google Patents

Compostos inibidores de catepsina g e de elastase para a prevencao da degenerescencia do tecido conjuntivo

Info

Publication number
PT100517A
PT100517A PT100517A PT10051792A PT100517A PT 100517 A PT100517 A PT 100517A PT 100517 A PT100517 A PT 100517A PT 10051792 A PT10051792 A PT 10051792A PT 100517 A PT100517 A PT 100517A
Authority
PT
Portugal
Prior art keywords
degenerescence
catepsin
prevention
inhibitor compounds
elastase inhibitor
Prior art date
Application number
PT100517A
Other languages
English (en)
Other versions
PT100517B (pt
Inventor
Philippe Bey
Michael Richard Angelastro
Niall Stephen Doherty
Michael John Janusz
Shujaath Mehdi
Norton Paul Peet
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of PT100517A publication Critical patent/PT100517A/pt
Publication of PT100517B publication Critical patent/PT100517B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0827Tripeptides containing heteroatoms different from O, S, or N
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/021Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)n-C(=0)-, n being 5 or 6; for n > 6, classification in C07K5/06 - C07K5/10, according to the moiety having normal peptide bonds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06191Dipeptides containing heteroatoms different from O, S, or N
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0802Tripeptides with the first amino acid being neutral
    • C07K5/0804Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02Linear peptides containing at least one abnormal peptide link
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Transceivers (AREA)
  • Mobile Radio Communication Systems (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Dental Preparations (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polymerisation Methods In General (AREA)
  • Vehicle Body Suspensions (AREA)
PT100517A 1991-05-23 1992-05-22 Derivados peptidicos inibidores de catepsina g e de elastase para a prevencao da degenerescencia do tecido conjuntivo PT100517B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US70449991A 1991-05-23 1991-05-23

Publications (2)

Publication Number Publication Date
PT100517A true PT100517A (pt) 1993-09-30
PT100517B PT100517B (pt) 1999-06-30

Family

ID=24829789

Family Applications (1)

Application Number Title Priority Date Filing Date
PT100517A PT100517B (pt) 1991-05-23 1992-05-22 Derivados peptidicos inibidores de catepsina g e de elastase para a prevencao da degenerescencia do tecido conjuntivo

Country Status (17)

Country Link
US (1) US5510333A (pt)
EP (1) EP0587799B1 (pt)
JP (1) JP3442075B2 (pt)
AT (1) ATE181925T1 (pt)
AU (1) AU655301B2 (pt)
DE (1) DE69229552T2 (pt)
DK (1) DK0587799T3 (pt)
ES (1) ES2136091T3 (pt)
FI (1) FI935172A0 (pt)
GR (1) GR3031005T3 (pt)
HU (1) HU217612B (pt)
IL (1) IL101925A (pt)
NO (1) NO934218L (pt)
NZ (1) NZ242807A (pt)
PT (1) PT100517B (pt)
WO (1) WO1992020357A1 (pt)
ZA (1) ZA923602B (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5714470A (en) * 1991-08-22 1998-02-03 Merrell Pharmaceuticals, Inc. Orally-active elastase inhibitors
EP0635028B1 (en) * 1992-04-10 2003-01-22 Abbott Laboratories Pulmonary surfactant protein fragments
JP2668003B2 (ja) * 1992-06-12 1997-10-27 ファイザー インク. ヒトの心臓キマーゼを含むアンギオテンシンiキマーゼに関する阻害剤
ES2137509T3 (es) * 1994-06-02 1999-12-16 Merrell Pharma Inc Perfluoroalquilcetonas, inhibidoras de elastasa y procedimientos para su preparacion.
ES2161293T3 (es) * 1994-06-02 2001-12-01 Merrell Pharma Inc Derivados de enol acilados como profarmacos de inhibidores de la elastasa.
US6017887A (en) * 1995-01-06 2000-01-25 Sibia Neurosciences, Inc. Peptide, peptide analog and amino acid analog protease inhibitors
US5804560A (en) * 1995-01-06 1998-09-08 Sibia Neurosciences, Inc. Peptide and peptide analog protease inhibitors
US5693515A (en) * 1995-04-28 1997-12-02 Arris Pharmaceutical Corporation Metal complexed serine protease inhibitors
DE19543750C2 (de) * 1995-11-24 1997-10-23 Crinos Industria Farmaco Cathepsin G inhibierende Aptamere
US5948886A (en) * 1996-11-20 1999-09-07 Hoechst Marion Roussel, Inc. Acylated enol derivatives of α-ketoesters and α-ketoamides
US6172044B1 (en) 1995-12-01 2001-01-09 Aventis Pharmaceuticals Inc. Acylated enol derivative of α-ketoesters and α-ketoamides
US6608030B1 (en) 1996-04-22 2003-08-19 Brigham & Women's Hospital, Inc. Suppression of immune response via inhibition of cathepsin S
JP2002047256A (ja) * 2000-07-26 2002-02-12 Kanegafuchi Chem Ind Co Ltd α−アミノ−α´,α´,α´−トリハロケトン誘導体、α−アミノ−α´,α´,α´−トリハロアルコ−ル誘導体、及び、α−ヒドロキシ−β−アミノカルボン酸誘導体の製造法
WO2008054144A1 (en) * 2006-11-03 2008-05-08 Amorepacific Corporation Skin external composition containing cathepsin g inhibitors for preventing skin aging and the screening method for development of antiaging materials
US8883857B2 (en) 2012-12-07 2014-11-11 Baylor College Of Medicine Small molecule xanthine oxidase inhibitors and methods of use
JP2023500182A (ja) 2019-09-17 2023-01-05 メレオ バイオファーマ 4 リミテッド 移植片拒絶反応、閉塞性細気管支炎症候群、及び移植片対宿主病の治療に使用するためのアルベレスタット
IL297211A (en) 2020-04-16 2022-12-01 Mereo Biopharma 4 Ltd Methods involving the neutrophil elastase inhibitor albalstat for the treatment of respiratory disease mediated by alpha-1 antitrypsin deficiency
KR20230038457A (ko) 2020-06-10 2023-03-20 알리고스 테라퓨틱스 인코포레이티드 코로나바이러스, 피코르나바이러스 및 노로바이러스 감염을 치료하기 위한 항바이러스 화합물
AU2022306289A1 (en) 2021-07-09 2024-01-18 Aligos Therapeutics, Inc. Anti-viral compounds
US12065428B2 (en) 2021-09-17 2024-08-20 Aligos Therapeutics, Inc. Anti-viral compounds
EP4419102A1 (en) 2021-10-20 2024-08-28 Mereo Biopharma 4 Limited Neutrophil elastase inhibitors for use in the treatment of fibrosis

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3230275A1 (de) * 1982-08-14 1984-02-16 Bayer Ag, 5090 Leverkusen Elastaseinhibitoren, verfahren zu ihrer herstellung sowie diese enthaltende arzneimittel
DE3324534A1 (de) * 1983-07-07 1985-01-17 Ciba-Geigy Ag, Basel Modifizierte protease-inhibitoren, verfahren zu ihrer herstellung und daraus bereitete pharmazeutische mittel
US4629724A (en) * 1984-12-03 1986-12-16 E. R. Squibb & Sons, Inc. Amino acid ester and amide renin inhibitors
US4643991A (en) * 1984-12-18 1987-02-17 The University Of Kentucky Research Foundation Peptide elastase inhibitors and methods
GB8600263D0 (en) * 1985-01-22 1986-02-12 Ici America Inc Peptide derivatives
US5055450A (en) * 1985-01-22 1991-10-08 Ici Americas Inc. Peptide derivatives
IL77748A (en) * 1985-02-04 1991-11-21 Merrell Dow Pharma Amino acid and peptide derivatives as peptidase inhibitors
DE3683541D1 (de) * 1985-06-07 1992-03-05 Ici America Inc Selektionierte difluorverbindungen.
GB8613703D0 (en) * 1986-06-05 1986-07-09 Ici America Inc Difluoro peptide compounds
NZ223148A (en) * 1987-01-16 1989-10-27 Merrell Dow Pharma Peptide derivatives having peptidase inhibition activity
EP0307662A3 (en) * 1987-08-24 1990-07-25 Kabushiki Kaisha Vitamin Kenkyusyo Enkephalin analogs
EP0356595A1 (en) * 1988-09-01 1990-03-07 Merrell Dow Pharmaceuticals Inc. Novel peptidase inhibitors
ZA897514B (en) * 1988-10-07 1990-06-27 Merrell Dow Pharma Novel peptidase inhibitors
ZA905737B (en) * 1989-07-26 1991-05-29 Merrell Dow Pharma Novel peptidase inhibitors
DE3938971A1 (de) * 1989-11-24 1991-05-29 Biotechnolog Forschung Gmbh Leukozytenelastase und kathepsin g blockierendes peptid, dna, vektor, wirtsorganismus und verfahren zu seiner gewinnung sowie pharmazeutisches praeparat

Also Published As

Publication number Publication date
NO934218D0 (no) 1993-11-22
HU217612B (hu) 2000-03-28
HU9303314D0 (en) 1994-03-28
IL101925A (en) 1996-03-31
HUT65140A (en) 1994-04-28
DK0587799T3 (da) 1999-11-22
NO934218L (no) 1993-11-22
JP3442075B2 (ja) 2003-09-02
AU2184192A (en) 1992-12-30
EP0587799A4 (en) 1995-06-14
IL101925A0 (en) 1992-12-30
EP0587799A1 (en) 1994-03-23
US5510333A (en) 1996-04-23
NZ242807A (en) 1994-07-26
WO1992020357A1 (en) 1992-11-26
PT100517B (pt) 1999-06-30
ATE181925T1 (de) 1999-07-15
DE69229552T2 (de) 1999-12-23
EP0587799B1 (en) 1999-07-07
AU655301B2 (en) 1994-12-15
GR3031005T3 (en) 1999-12-31
ZA923602B (en) 1993-02-24
DE69229552D1 (de) 1999-08-12
ES2136091T3 (es) 1999-11-16
JPH06508355A (ja) 1994-09-22
FI935172A (fi) 1993-11-22
FI935172A0 (fi) 1993-11-22

Similar Documents

Publication Publication Date Title
PT100517A (pt) Compostos inibidores de catepsina g e de elastase para a prevencao da degenerescencia do tecido conjuntivo
DK0793674T3 (da) Inhibitorer af human neutrofil elastase
TR199801151T2 (xx) Trombin inhibit�r� �n ila�lar.
ES2196190T3 (es) Inhibidores de metaloproteinasas matriciales, con hidroxamato bifenlico.
FI972935A0 (fi) Kalpaiinin ja/tai katepsiini B:n substituoituja oksatsolidiiniestäjiä
FI944804A0 (fi) Pyrimidinyyliasetamideja elastaasin estäjinä
NO20006718D0 (no) Proteaseinhibitorer
ID18142A (id) Inhibitor metaloprotease 1,4-heterosiklik
ID18141A (id) Inhibitor metaloprotease 1,3-diheterosiklik
NO942549D0 (no) Humanproteaseinhibitorvariant av Kunitz-type
DE69635447D1 (de) Plasma-kallikrein inhibitoren vom kunitz-typ
TR199800773T2 (xx) Trombin inhibit�rleri.
PT831826E (pt) Composicao farmaceutica que inclui um inibidor de proteinase e um monoglicerideo
BR0110506A (pt) Uso de inibidores de il-18 para o tratamento e/ou prevenção da aterosclerose
NO911956D0 (no) Oxydant sensitive og insensitive aromatiske estere som inhibitorer for human neutrofilelastase.
SE9601556D0 (sv) New pharmaceutical formulation of a thrombin inhibitor for parenteral use
FI962073A (fi) HIV-proteaasin estäjän prodrug-muotoja
AR021241A1 (es) Inhibidores de proteasas
DE59406224D1 (de) Metallhalogenid-hochdruckentladungslampe für den einbau in optische systeme
BR0213099A (pt) Compostos policìclicos de 5 membros substituìdos úteis para inibição seletiva da cascata de coagulação
CA2109516A1 (en) Inhibitors of cathepsin g and elastase for preventing connective tissue degradation
WO2003028621A3 (de) Proteinaseinhibitoren zur therapie und diagnose von neurodegenerativen erkrankungen
MY140504A (en) Statin-mmp inhibitor combinations
NO975534L (no) Imidazo-£1,5|-pyridin-avledete serinproteaseinhibitorer
BR9612344A (pt) Inibidores de proteases

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19930317

FG3A Patent granted, date of granting

Effective date: 19990315

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20040915